About Index Trending news
Analyze
Pricing
Promethera Biosciences

Promethera Biosciences

Promethera Biosciences

Promethera Biosciences is a biopharmaceutical company focused on cell therapyproducts to treat liver diseases.
I work here Suggest edits
More info

Elsewhere

Companies in the same industry

Cidara Therapeutics Cidara Therapeutics Denali Therapeutics Denali Therapeutics OptiKira OptiKira Lantern Pharma Inc Lantern Pharma Inc Encore Vision Inc. Encore Vision Inc. Topix Pharmaceuticals, Inc. Topix Pharmaceuticals, Inc. Enumeral Biomedical Holdings, Inc. Enumeral Biomedical Holdings, Inc. Aptevo Therapeutics Aptevo Therapeutics Hookipa Biotech Hookipa Biotech Confo Therapeutics Confo Therapeutics

Alexa global traffic share

Terms of Service API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2017
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Funding 4
Add info
Latest funding Show all
Venture capital (Series C)
€10,000,000
Mitsui & Co. Global Investment, Mitsubishi UFJ Capital, Vesalius Biocapital Partners, +4
Venture capital (Series C)
$31,444,456
Employees

Team size

10+
Locations
HQ
Belgium
Headquarters
€10,000,000 Venture capital (Series C)
businesswire

Promethera Biosciences Raises EUR 10 Million in a Series C-extension Financing to Advance its Broad Product Pipeline in Liver Diseases | Business Wire

Promethera Biosciences
Promethera Biosciences